Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.

Background: Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections (ROYBSIs) are rare, even in cancer patients.Methods: We retrospectively reviewed all episodes of ROYBSIs occurring from 1998 to 2010 in our cancer center.Results: Of 2984 blood cultures positive for Candida a...

Full description

Bibliographic Details
Published in:Journal of Infection Vol. 64; no. 1; pp. 68 - 76
Main Authors: Chitasombat MN, Kofteridis DP, Jiang Y, Tarrand J, Lewis RE, Kontoyiannis DP, Chitasombat, Maria N, Kofteridis, Diamantis P, Jiang, Ying, Tarrand, Jeffrey, Lewis, Russell E, Kontoyiannis, Dimitrios P
Format: research Journal Article
Published: W B Saunders Jan2012
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104434975&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 104434975
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01634453
        8IL
      jtl: Journal of Infection
      issn: 01634453
      maglogo: N
    pubinfo:
      dt: Jan2012
      vid: 64
      iid: 1
      pid: 1351
      pub: W B Saunders
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        104434975
        NLM22101079
        2011732652
        10.1016/j.jinf.2011.11.002
        NLM22101079
        PMC3855381
        104434975
      ppf: 68
      ppct: 8
      formats:
      tig:
        atl: Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections in patients with cancer.
      aug:
        au:
          Chitasombat MN
          Kofteridis DP
          Jiang Y
          Tarrand J
          Lewis RE
          Kontoyiannis DP
          Chitasombat, Maria N
          Kofteridis, Diamantis P
          Jiang, Ying
          Tarrand, Jeffrey
          Lewis, Russell E
          Kontoyiannis, Dimitrios P
        affil: Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
      sug:
        subj:
          Fungemia Epidemiology
          Fungemia Microbiology
          Neoplasms Complications
          Opportunistic Infections Epidemiology
          Opportunistic Infections Microbiology
          Yeasts Classification
          Yeasts
          Adolescence
          Adult
          Aged
          Aged, 80 and Over
          Antifungal Agents Administration and Dosage
          Antifungal Agents Pharmacodynamics
          Catheter-Related Infections Epidemiology
          Catheter-Related Infections Microbiology
          Catheter-Related Infections Mortality
          Child
          Drug Resistance, Microbial
          Female
          Fungemia Mortality
          Human
          Male
          Middle Age
          Opportunistic Infections Mortality
          Retrospective Design
          Survival Analysis
          Yeasts Drug Effects
          Young Adult
          Adolescent: 13-18 years
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Child: 6-12 years
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: Rare opportunistic (non-Candida, non-Cryptococcus) yeast bloodstream infections (ROYBSIs) are rare, even in cancer patients.Methods: We retrospectively reviewed all episodes of ROYBSIs occurring from 1998 to 2010 in our cancer center.Results: Of 2984 blood cultures positive for Candida and non-Candida yeasts, 94 (3.1%) were positive for non-Candida yeasts, representing 41 ROYBSIs (incidence, 2.1 cases/100,000 patient-days). Catheter-associated fungemia occurred in 21 (51%) patients. Breakthrough ROYBSIs occurred in 20 (49%) patients. The yeast species distribution was Rhodotorula in 21 (51%) patients, Trichosporon in 8 (20%) patients, Saccharomyces cerevisiae in 8 (20%) patients, Geotrichum in 2 (5%) patients, Pichia anomala, and Malassezia furfur in 1 patient each. All tested Trichosporon, Geotrichum, and Pichia isolates were azole-susceptible, whereas the Rhodotorula isolates were mostly azole-resistant. We noted echinocandin nonsusceptibility (minimal inhibitory concentration ≥ 2 mg/L) in all but the S. cerevisiae isolates. Most of the isolates (28/33 [85%]) were susceptible to amphotericin B. The mortality rate in all patients at 30 days after ROYBSIs diagnosis was 34%. Multivariate survival analysis revealed increased risk of death in patients with S. cerevisiae infections (hazard ratio, 3.7), Geotrichum infections (hazard ratio, 111.3), or disseminated infections (hazard ratio, 33.4) and reduced risk in patients who had catheter removal (hazard ratio, 0.1).Conclusions: ROYBSIs are uncommon in patients with cancer, and catheters are common sources of them. Half of the ROYBSIs occurred as breakthrough infections, and in vitro species-specific resistance to echinocandins and azoles was common. Disseminated infections resulted in the high mortality rate.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N